Clinical significance of breakthrough phenomenon in liver transplant patients with recurrent hepatitis C treated with Interferon-ALPHA and Ribavirin.

被引：0
|
作者：
Nasir, A [1 ]
Smallwood, GA [1 ]
Stieber, AC [1 ]
Heffron, TG [1 ]
De Vera, ME [1 ]
机构：
[1] Emory Univ Hosp, Atlanta, GA 30322 USA
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
418
引用
收藏
页码：A78 / A78
页数：1
相关论文
共 50 条
  • [41] Detectable levels of IgM antibodies to hepatitis C virus core protein predict breakthrough in patients with chronic hepatitis C treated with interferon-alpha
    Fracassetti, O
    Tambini, R
    Perani, V
    Vicari, O
    Lorenzi, N
    Delvecchio, G
    [J]. JOURNAL OF VIRAL HEPATITIS, 1996, 3 (05) : 265 - 266
  • [42] Response rate of hepatitis C patients treated with high dose Interferon Alfa 2a with Ribavirin and Interferon Alfacon-1 with Ribavirin.
    Islam, KK
    Sokhi, RP
    Kim, KS
    Nadir, A
    Shah, N
    Harig, JM
    Van Thiel, DH
    [J]. HEPATOLOGY, 2001, 34 (04) : 621A - 621A
  • [43] Serious psychiatric adverse events in chronic Hepatitis C patients treated with Pegylated or recombinant Interferon-Alpha plus Ribavirin
    Drozdz, W.
    Borkowska, A.
    Kozielewz, D.
    Dybowska, D.
    Ziolkowska-Kochan, M.
    Halota, W.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S366 - S367
  • [44] Preliminary report:: Study of bone mass and mineral metabolism in chronic hepatitis C male patients treated with alpha-interferon and ribavirin.
    Martínez, G
    Jodar, E
    Soto, A
    Hawkins, F
    Solis-Herruzo, JA
    [J]. BONE, 2001, 28 (05) : S117 - S117
  • [45] Consensus Interferon for Recurrent Hepatitis C Infection in Nonresponders to Peginterferon and Ribavirin After Liver Transplant
    Nordstrom, Eric M.
    Biggins, Scott W.
    Gralla, Jane
    Rosen, Hugo R.
    Everson, Gregory T.
    Burton, James R., Jr.
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2015, 13 (06) : 543 - 549
  • [46] Interferon-gamma with interferon-alpha and ribavirin for hepatitis C non-responders
    Raza, S.
    Abbas, Z.
    Jafri, W.
    Hameed, S.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 44 - 44
  • [47] A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C
    Shakil, AO
    McGuire, B
    Crippin, J
    Teperman, L
    Demetris, AJ
    Conjeevaram, H
    Gish, R
    Kwo, P
    Balan, V
    Wright, TL
    Brass, C
    Rakela, J
    [J]. HEPATOLOGY, 2002, 36 (05) : 1253 - 1258
  • [48] Pegylated interferon therapy with/without ribavirin in liver transplant recipients with recurrent hepatitis C infection
    Levitsky, J
    Cohen, SM
    Dasgupta, KA
    Faust, TW
    Te, HS
    [J]. HEPATOLOGY, 2002, 36 (04) : 182A - 182A
  • [49] Treatment of Recurrent Hepatitis C in Liver Transplant Recipients With Extended Duration of Pegylated Interferon and Ribavirin
    Arrigo, Richard
    Samanta, Arun
    Griffith, Shanthini
    Parekh, Ravish M.
    Korogodsky, Maria
    Rao, Kiran V.
    Fisher, Adrian
    Wilson, Dorian
    Klein, Kenneth M.
    Koneru, Baburao
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S459 - S459
  • [50] The risk of acute rejection in patients treated with pegylated interferon and ribavirin for recurrent hepatitis C post liver transplantation
    Elhajj, N
    Kontorinis, N
    Agarwal, K
    Schwartz, M
    Roayaie, S
    Schiano, TD
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A700 - A700
12345